Sunshine Biopharma, Inc. (SBFM) Balance Sheet
SBFM balance sheet, 2025
December 31, 2025 · U.S. dollars$30.1M assets = $7.0M liabilities + $23.0M equity
Both columns are drawn to the same scale: what SBFM owns equals what it owes plus shareholders’ equity. Hover a block for its value.
SBFM financial health
Descriptive bands, not a rating. Fiscal 2025.
SBFM balance sheet trends, 2016–2025
| Metric | Trend | Then | Latest | Change |
|---|---|---|---|---|
| Total assets | $64,4042016 | $30.1M2025 | +98.0%/yr | |
| Total liabilities | $274,1042016 | $7.0M2025 | +43.4%/yr | |
| Shareholders’ equity | −$209,7002016 | $23.0M2025 | — | |
| Cash & short-term investments | $57,4532016 | $9.1M2025 | +75.6%/yr | |
| Total debt | $236,9712016 | $812,4222025 | +14.7%/yr | |
| Net cash (debt) | −$179,5182016 | $8.3M2025 | +$8.5M | |
| Working capital | −$215,6442016 | $20.4M2025 | +$20.6M | |
| Current ratio | 0.212016 | 4.172025 | +3.95 | |
| Debt / equity | 8.982021 | 0.042025 | −8.94 |
Change is the average annual growth (CAGR) or the difference between the first and latest year.
SBFM assets
SBFM liabilities and equity
SBFM debt vs cash
Debt includes short- and long-term borrowings and, where reported, lease obligations.
SBFM balance sheet
| 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Assets | ||||||||||
| Cash & short-term investments | $9.1M | $9.7M | $16.3M | $21.8M | $2.0M | $997,478 | $48,091 | $115,216 | $107,532 | $57,453 |
| Cash & equivalents | $9.1M | $9.7M | $16.3M | $21.8M | $2.0M | $989,888 | $40,501 | $115,216 | $107,532 | $57,453 |
| Short-term investments | — | — | — | — | $7,590 | $7,590 | $7,590 | — | — | — |
| Receivables | $3.5M | $3.9M | $2.6M | $1.9M | $7,798 | $1,916 | $430 | $94,955 | $9,667 | $0 |
| Inventory | $13.5M | $11.3M | $5.7M | $3.3M | $105,650 | $23,771 | $15,910 | $0 | −$9,667 | $0 |
| Other current assets | $798,384 | $1.1M | $310,591 | $283,799 | $37,215 | $2,778 | $1,255 | $1,341 | $9,667 | $1,007 |
| Total current assets | $26.9M | $26.0M | $24.9M | $27.3M | $2.2M | $1.0M | $65,686 | $211,512 | $117,199 | $58,460 |
| Property, plant & equipment (net) | $1.3M | $1.5M | $1.0M | $1.2M | $7,061 | $19,531 | $32,456 | $269,362 | $59,996 | $5,944 |
| Goodwill & intangible assets | $1.9M | $3.0M | $1.4M | $776,856 | $0 | $0 | $0 | $665,697 | $0 | $0 |
| Long-term investments | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $0 |
| Other non-current assets | $0 | $92,234 | $0 | $301,293 | $0 | $0 | $0 | $0 | $80,290 | $0 |
| Total assets | $30.1M | $30.6M | $27.3M | $29.5M | $2.2M | $1.0M | $98,142 | $1.1M | $257,485 | $64,404 |
| Liabilities | ||||||||||
| Accounts payable | $5.7M | $5.5M | $2.6M | $2.8M | $42,942 | $62,869 | $96,882 | $115,826 | $19,314 | $28,122 |
| Short-term debt | $215,637 | $207,756 | $118,670 | $123,026 | $1.9M | $964,115 | $715,568 | $662,757 | $722,609 | $236,971 |
| Deferred revenue | — | — | $299,869 | — | — | — | — | $49,349 | — | — |
| Total current liabilities | $6.4M | $6.3M | $5.6M | $6.9M | $91,229 | $1.1M | $833,527 | $912,477 | $751,138 | $274,104 |
| Long-term debt | $0 | $0 | $0 | $0 | $1.9M | $949,006 | $0 | $289,847 | $79,710 | $0 |
| Lease obligations | $812,422 | $952,480 | $657,705 | $642,232 | $0 | — | — | — | — | — |
| Other long-term liabilities | $596,785 | $744,724 | $587,764 | $986,556 | $0 | $0 | $812,450 | $0 | $0 | $265,093 |
| Total liabilities | $7.0M | $7.1M | $6.1M | $7.9M | $2.0M | $2.0M | $833,527 | $1.2M | $830,848 | $274,104 |
| Shareholders' equity | ||||||||||
| Common stock & paid-in capital | $4,905 | $2,580 | $28,024 | $22,585 | $2,591 | $1,732 | $35,320 | $85,652 | $918,736 | $769,400 |
| Retained earnings (deficit) | −$75.0M | −$69.0M | −$63.9M | −$59.4M | −$32.7M | −$20.2M | −$17.4M | −$15.8M | −$13.6M | −$12.6M |
| Accumulated other comprehensive income | −$65,309 | −$829,959 | $696,105 | $161,847 | −$23,139 | −$2,871 | −$2,495 | −$3,738 | $504 | $394 |
| Total shareholders' equity | $23.0M | $23.5M | $21.2M | $21.6M | $211,662 | −$954,837 | −$735,385 | −$55,753 | −$573,363 | −$209,700 |
| Key figures | ||||||||||
| Total debt | $812,422 | $952,480 | $657,705 | $765,258 | $1.9M | $1.9M | $715,568 | $952,604 | $802,319 | $236,971 |
| Net cash (debt) | $8.3M | $8.7M | $15.6M | $21.1M | $145,167 | −$915,643 | −$667,477 | −$837,388 | −$694,787 | −$179,518 |
| Working capital | $20.4M | $19.7M | $19.3M | $20.4M | $2.1M | −$25,362 | −$767,841 | −$700,965 | −$633,939 | −$215,644 |
| Tangible book value | $21.1M | $20.5M | $19.8M | $20.9M | $211,662 | −$954,837 | −$735,385 | −$721,450 | −$573,363 | −$209,700 |
| Current ratio | 4.17 | 4.11 | 4.48 | 3.94 | 24.07 | 0.98 | 0.08 | 0.23 | 0.16 | 0.21 |
| Quick ratio | 1.95 | 2.15 | 3.39 | 3.42 | 22.50 | 0.95 | 0.06 | 0.23 | 0.16 | 0.21 |
| Debt / equity | 0.04 | 0.04 | 0.03 | 0.04 | 8.98 | — | — | — | — | — |
| Equity / assets | 76.6% | 76.9% | 77.5% | 73.2% | 9.6% | −91.3% | −749.3% | −4.9% | −222.7% | −325.6% |
| Jun '26 | Mar '26 | Dec '25 | Sep '25 | Jun '25 | Mar '25 | Dec '24 | Sep '24 | Jun '24 | Mar '24 | Dec '23 | Sep '23 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Assets | ||||||||||||
| Cash & short-term investments | $13.7M | $6.9M | $9.1M | $9.3M | $10.3M | $8.2M | $9.7M | $12.2M | $11.5M | $17.4M | $16.3M | $18.8M |
| Cash & equivalents | $13.7M | $6.9M | $9.1M | $9.3M | $10.3M | $8.1M | $9.7M | $12.2M | $11.5M | $17.4M | $16.3M | $18.8M |
| Short-term investments | — | — | — | — | — | $70,457 | — | — | — | — | — | — |
| Receivables | $4.0M | $4.0M | $3.5M | $4.2M | $3.6M | $3.4M | $3.9M | $3.2M | $4.0M | $2.8M | $2.6M | $2.0M |
| Inventory | $12.1M | $13.2M | $13.5M | $14.1M | $13.0M | $11.9M | $11.3M | $9.8M | $8.5M | $7.7M | $5.7M | $4.5M |
| Other current assets | $759,970 | $690,102 | $798,384 | $441,490 | $939,436 | $983,536 | $1.1M | $735,796 | $1.8M | $871,390 | $310,591 | $37,556 |
| Total current assets | $30.7M | $24.8M | $26.9M | $28.0M | $27.9M | $24.5M | $26.0M | $26.0M | $25.7M | $28.8M | $24.9M | $25.4M |
| Property, plant & equipment (net) | $1.1M | $1.2M | $1.3M | $1.4M | $1.5M | $1.4M | $1.5M | $1.1M | $1.1M | $1.0M | $1.0M | $999,218 |
| Goodwill & intangible assets | $1.8M | $1.9M | $0 | $2.0M | $2.5M | $3.2M | $0 | $2.9M | $2.4M | $2.1M | $1.4M | $1.2M |
| Long-term investments | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $0 |
| Other non-current assets | $0 | $0 | $1.9M | $92,234 | $92,233 | $92,234 | $3.1M | $0 | $0 | $0 | $0 | $0 |
| Total assets | $33.6M | $27.9M | $30.1M | $31.5M | $32.0M | $29.2M | $30.6M | $30.1M | $29.3M | $31.9M | $27.3M | $27.7M |
| Liabilities | ||||||||||||
| Accounts payable | $4.9M | $5.1M | $5.7M | $6.1M | $4.8M | $5.0M | $5.5M | $4.2M | $4.9M | $3.6M | $2.6M | $2.2M |
| Short-term debt | $202,518 | $209,226 | — | $218,053 | $222,496 | $213,983 | — | $116,253 | $114,452 | $115,398 | $118,670 | $117,840 |
| Deferred revenue | — | — | — | — | — | — | — | $138,718 | −$114,452 | $254,971 | $299,869 | −$2.3M |
| Total current liabilities | $5.6M | $5.9M | $6.4M | $6.7M | $5.6M | $5.8M | $6.3M | $4.5M | $5.3M | $6.5M | $5.6M | $5.1M |
| Long-term debt | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $0 |
| Lease obligations | $678,338 | $744,840 | $812,422 | $854,761 | $929,026 | $936,182 | $952,480 | $556,551 | $577,358 | $612,366 | $657,705 | $673,527 |
| Other long-term liabilities | $475,820 | $535,613 | $596,785 | $636,708 | $706,530 | $722,199 | $744,724 | $489,027 | $511,635 | $545,696 | $587,764 | $598,719 |
| Total liabilities | $6.1M | $6.4M | $7.0M | $7.3M | $6.3M | $6.5M | $7.1M | $5.0M | $5.8M | $7.1M | $6.1M | $5.7M |
| Shareholders' equity | ||||||||||||
| Common stock & paid-in capital | $2,389 | $4,905 | — | $4,555 | $4,555 | $2,707 | — | $2,000 | $1,171 | $995 | $28,024 | $25,678 |
| Retained earnings (deficit) | −$77.8M | −$76.3M | −$75.0M | −$72.9M | −$72.0M | −$70.2M | −$69.0M | −$66.9M | −$65.7M | −$65.2M | −$63.9M | −$62.7M |
| Accumulated other comprehensive income | −$658,935 | −$343,306 | — | −$320,841 | $280,787 | −$803,770 | — | $168,589 | −$683,050 | $152,400 | $696,105 | $204,549 |
| Total shareholders' equity | $27.5M | $21.5M | $23.0M | $24.2M | $25.7M | $22.7M | $23.5M | $25.0M | $23.5M | $24.8M | $21.2M | $22.0M |
| Key figures | ||||||||||||
| Total debt | $678,338 | $744,840 | — | $854,761 | $929,026 | $936,182 | — | $556,551 | $577,358 | $612,366 | $657,705 | $673,527 |
| Net cash (debt) | $13.1M | $6.2M | — | $8.5M | $9.4M | $7.3M | — | $11.7M | $10.9M | $16.8M | $15.6M | $18.2M |
| Working capital | $25.0M | $18.9M | $20.4M | $21.3M | $22.3M | $18.7M | $19.7M | $21.5M | $20.4M | $22.3M | $19.3M | $20.3M |
| Tangible book value | $25.7M | $19.6M | $23.0M | $22.2M | $23.2M | $19.5M | $23.5M | $22.1M | $21.0M | $22.8M | $19.8M | $20.7M |
| Current ratio | 5.46 | 4.22 | 4.17 | 4.20 | 5.00 | 4.25 | 4.11 | 5.74 | 4.86 | 4.41 | 4.48 | 5.00 |
| Quick ratio | 3.16 | 1.86 | 1.95 | 2.02 | 2.49 | 2.02 | 2.15 | 3.41 | 2.92 | 3.10 | 3.39 | 4.10 |
| Debt / equity | 0.02 | 0.03 | — | 0.04 | 0.04 | 0.04 | — | 0.02 | 0.02 | 0.02 | 0.03 | 0.03 |
| Equity / assets | 81.9% | 77.0% | 76.6% | 76.9% | 80.4% | 77.8% | 76.9% | 83.3% | 80.2% | 77.8% | 77.5% | 79.4% |
Quarterly columns are labeled by the month the quarter ended. Figures in U.S. dollars as reported (latest annual report filed April 3, 2026); data from EODHD.
SBFM financial position
At the end of fiscal 2025 (December 31, 2025), Sunshine Biopharma had total assets of $30.1 million (down 1.6% from a year earlier), total liabilities of $7.0 million and shareholders' equity of $23.0 million. It held $9.1 million in cash and short-term investments against $0.8 million of debt, a net cash position of $8.3 million. Its current ratio was 4.17. In the latest quarter (ended June 30, 2026) total assets were $33.6 million and equity $27.5 million.
Related: SBFM income statement, SBFM cash flow statement, SBFM key metrics. See the SBFM stock overview for the latest quote and news.
SBFM balance sheet FAQ
What are Sunshine Biopharma's total assets?
Sunshine Biopharma reported total assets of $30.1 million at the end of fiscal 2025 (December 31, 2025), compared with $30.6 million a year earlier.
How much debt does Sunshine Biopharma have?
Sunshine Biopharma had $0.8 million of total debt at the end of fiscal 2025, including short-term borrowings and lease obligations. Its debt-to-equity ratio was 0.04.
How much cash does Sunshine Biopharma have?
Sunshine Biopharma held $9.1 million in cash and short-term investments at the end of fiscal 2025; with $0.8 million of debt that is net cash of $8.3 million.
What is Sunshine Biopharma's book value?
Sunshine Biopharma's shareholders' equity (book value) was $23.0 million at the end of fiscal 2025.
What is Sunshine Biopharma's current ratio?
Sunshine Biopharma had current assets of $26.9 million and current liabilities of $6.4 million, a current ratio of 4.17 (it can cover its short-term obligations).
How much goodwill does Sunshine Biopharma have?
Sunshine Biopharma carried $1.9 million of goodwill and intangible assets, 6.3% of total assets, at the end of fiscal 2025.